ARN-509 (Apalutamide): Mechanism of Action

ARN-509 (Apalutamide) MOA:Targeting Androgen Receptor/Androgen Signaling Pathway for High-Risk Localized Prostate Cancer

🎯 check ARN-509 (Apalutamide) product page

ARN-509 is a selective AR antagonist. It affects AR signaling by blocking nuclear translocation, inhibiting tumor cell growth.

Primary Applications and Mechanism of Action